Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: Bilateral tonic-clonic seizure, Microcephaly, Moderate intellectual disability, and Aggressive behavior and others; and common findings: Slender build and Pes planus.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 5 | Bilateral tonic-clonic seizure, Moderate intellectual disability, Aggressive behavior |
SARS1 function has not been fully characterized.
Neurodevelopmental disorder with microcephaly, ataxia, and seizures has limited evidence linking it to mutations in the SARS1 gene on chromosome 1.
Genetic testing for SARS1 is available. Testing is considered research-grade for diagnosis.
Phenotype severity distribution: 7 always present features, 2 common features.
No clinical trials have been registered for neurodevelopmental disorder with microcephaly, ataxia, and seizures.
17 publications have been identified in PubMed for neurodevelopmental disorder with microcephaly, ataxia, and seizures. Research spans Case Report / Case Series (36%), Epidemiology / Natural History (29%), and Basic Science / Preclinical (21%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 5 | 36% |
Data assembled from 6 of 12 sources · Last updated Sep 20, 2026, 11:32 AM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Head and neck |
1 |
Microcephaly |
Muscles | 1 | Muscle weakness |
Age of onset: infancy, adolescence.
Disease patterns and progression |
4 |
29% |
Laboratory research | 3 | 21% |
Research summaries | 2 | 14% |
Rakotomamonjy J (2026). [PMID: 41867234](https://pubmed.ncbi.nlm.nih.gov/41867234/). *medRxiv*. [Basic Science / Preclinical]
Wei L (2026). [PMID: 41437736](https://pubmed.ncbi.nlm.nih.gov/41437736/). *Autism Res*. [Basic Science / Preclinical]
Hwang S (2026). [PMID: 41152456](https://pubmed.ncbi.nlm.nih.gov/41152456/). *J Hum Genet*. [Epidemiology / Natural History]
Abdel-Salam GMH (2026). [PMID: 41436176](https://pubmed.ncbi.nlm.nih.gov/41436176/). *J Med Genet*. [Epidemiology / Natural History]
Rezaei Z (2026). [PMID: 41825724](https://pubmed.ncbi.nlm.nih.gov/41825724/). *Eur J Med Genet*. [Epidemiology / Natural History]
Aughey GN (2025). [PMID: 39692517](https://pubmed.ncbi.nlm.nih.gov/39692517/). *Brain*. [Case Report / Case Series]
Sorrentino U (2025). [PMID: 39417375](https://pubmed.ncbi.nlm.nih.gov/39417375/). *Am J Med Genet B Neuropsychiatr Genet*. [Case Report / Case Series]
Sandal P (2025). [PMID: 39565297](https://pubmed.ncbi.nlm.nih.gov/39565297/). *Hum Mol Genet*. [Basic Science / Preclinical]
Zhang H (2025). [PMID: 39487674](https://pubmed.ncbi.nlm.nih.gov/39487674/). *IUBMB Life*. [Review / Meta-Analysis]
Peng X (2025). [PMID: 40555653](https://pubmed.ncbi.nlm.nih.gov/40555653/). *Zhonghua Yi Xue Yi Chuan Xue Za Zhi*. [Case Report / Case Series]